W. R. Berkley Corporation announced the passing of its founder and Executive Chairman, William R. Berkley, at the age of 80. Mr. Berkley founded the company in 1967 and built it into a Fortune 500 commercial insurance organization over nearly six decades. Following his death, the Board of Directors has appointed W. Robert Berkley, Jr. as Chairman, effective immediately.

W. Robert Berkley, Jr., President and Chief Executive Officer, highlighted his father's influence as a leader and entrepreneur. He emphasized the founder's vision, values, and commitment to underwriting excellence and long-term results. The CEO noted that William R. Berkley's impact on the company, the insurance industry, and countless individuals is immeasurable.

Beyond his business achievements, the late founder was dedicated to philanthropy, focusing on education and healthcare. He supported educational institutions at all levels to expand opportunity and foster intellectual curiosity. His contributions also extended to healthcare, where he backed hospitals, research institutions, and community-based programs to improve patient care.

W. R. Berkley Corporation operates as an insurance holding company and is among the largest commercial lines writers in the United States. The company operates two segments: Insurance and Reinsurance & Monoline Excess.

Goldman Sachs analyst Robert Cox has upgraded W. R. Berkley Corporation from Neutral to Buy and raised the price target to $73 from the previous $71. This positive revision contrasts with recent bearish sentiment from other Wall Street analysts. The new target suggests potential upside from current levels, as WR Berkley shares recently closed at $68.57.

Separately, Wells Fargo analyst Elyse Greenspan had previously downgraded W. R. Berkley Corporation, reducing the stock's rating from Equal-Weight to Underweight and lowering the price target to $58 from $64. Meanwhile, HC Wainwright & Co. analyst Robert Burns downgraded ADC Therapeutics SA from Buy to Neutral, with shares closing at $1.0250.

Analyst Rating Changes

The following table summarizes the recent analyst actions:

The divergent ratings highlight varying valuation expectations and market outlooks for these firms.